European Association for the Study of Diabetes

European Association for the Study of Diabetes Promoting excellence in diabetes care since 1965. The European Association for the Study of Diabetes e.V.
(1)

(EASD) is a membership-based academic non-profit organization. It was founded in 1965 and its headquarters is based in Duesseldorf, Germany. EASD is a networks for diabetologists with active members from all over the world. Membership is open to scientists, physicians, students, postdocs and fellows, allied health professionals and nurses who are interested in the field of diabetes or related diseases. The EASD Annual Meeting is one of the largest diabetes conferences in the world, attracting thousands of delegates each year. The scientific programme includes hundreds of talks, presentations and discussions on the latest results from basic and clinical diabetes research. EASD is also a leading player in postgraduate education having trained thousands of healthcare professionals through dedicated training courses and online education activities. Our award winning e-Learning platform, offers free access to courses developed with world-class experts in diabetes research and care. The Association is actively involved in producing and endorsing statements and guidelines translating the latest results from diabetes research into best practices in diabetes management. These statements and guidelines have proven to have significant visibility and substantial impact on health care, particularly when concerning statements on treatment and diagnostic criteria. By creating the Early Career Academy, EASD has increased its commitment to support, train, mentor, and create opportunities for scientists, clinicians, and students who are at an early or intermediate stage of their career. The European Foundation for the Study of Diabetes (EFSD) was founded by EASD in 2000 to stimulate diabetes research in Europe. EFSD offers support in all areas of diabetes research through a wide range of joint and stand-alone initiatives. Funding streams are available throughout the year and since inception, EFSD has committed over €120 million to diabetes research in Europe. EASD is also the publisher of Diabetologia, a major monthly international diabetes journal with an impact factor of 8.2 (2022). The journal publishes original clinical, translational and experimental research on all aspects of diabetes and related subjects. For more information about EASD, please visit: www.easd.org

🎙️💊 Can a pill transform obesity and diabetes care? In the latest EASD TV Podcast, Dr. Sean Wharton and Dr. Nasreen Alfa...
14/11/2025

🎙️💊 Can a pill transform obesity and diabetes care? In the latest EASD TV Podcast, Dr. Sean Wharton and Dr. Nasreen Alfaris discuss the results of the ATTAIN trial, introducing Orforglipron (the first oral small molecule GLP-1 agonist).

From weight loss and prevention to global access and affordability, this conversation explores what could be a turning point in diabetes and obesity treatment.

🎧 Listen now: https://www.easd.org/media-centre/podcasts.html

✈️💙 Today is World Diabetes Day. This year’s theme, “Diabetes and the workplace,” highlights how diabetes affects profes...
14/11/2025

✈️💙 Today is World Diabetes Day. This year’s theme, “Diabetes and the workplace,” highlights how diabetes affects professionals across all fields even those working thousands of metres above the ground.

Did you know that in most countries, people living with diabetes cannot become or remain pilots or air traffic controllers (ATCOs)? Thanks to evolving regulations and research like the EASA - European Union Aviation Safety Agency Diabetes Project, led by Prof. Julia Mader of the Medizinische Universität Graz, the skies are becoming more inclusive! By testing how diabetes technologies perform under aviation conditions, the project is creating evidence-based frameworks that allow qualified pilots and air traffic controllers with diabetes to continue their work safely.

This World Diabetes Day, we celebrate the intersection of innovation, inclusion, and safety, proving that with the right research and technology, the sky is NOT the limit.

🔗👉 Read the full story: https://www.easd.org/worlddiabetesday2025/

🗣️💻 Tomorrow, join Prof. Gernot Desoye (Medizinische Universität Graz) and the EASD Early Career Academy for a   webinar...
13/11/2025

🗣️💻 Tomorrow, join Prof. Gernot Desoye (Medizinische Universität Graz) and the EASD Early Career Academy for a webinar exploring how the placenta influences diabetes during pregnancy.

🗓️ 14 November 2025 | 🕛 16:00 CET

Gain insights into maternal-fetal interactions and their impact on both mother and child. Don’t miss this opportunity to learn from a leading expert!

Register now 👉 https://us06web.zoom.us/webinar/register/WN_5yWiAvvQSSutjto__7GVSw #/registration

🔁 The EASD Early Career Academy continues its series!

Next up on : Prof. Gernot Desoye (Medizinische Universität Graz) explores how the placenta influences pregnancy outcomes and fetal development.

Don’t miss this insightful session on 📅 14 November 2025 | 🕛 16:00 pm CET

Register now 👉 https://us06web.zoom.us/webinar/register/WN_5yWiAvvQSSutjto__7GVSw #/registration

Join us in congratulating the 2025  /Novo Nordisk A/S Programme for Diabetes Research in Europe recipients 🎉The award is...
13/11/2025

Join us in congratulating the 2025 /Novo Nordisk A/S Programme for Diabetes Research in Europe recipients 🎉

The award is a collaborative funding initiative to support both basic and clinical diabetes research across Europe, offering grants to researchers at non-profit institutions who are members of EASD. Its main goal is to foster innovation in all areas of diabetes research, from fundamental science to clinical applications, helping to advance knowledge and potential treatments for the disease.

Learn more about the projects 👉 https://www.europeandiabetesfoundation.org/recipients/efsd-nn-as-diab-research-europe/

This award programme is generously supported by Novo Nordisk.

Congratulations to all the recipients and we look forward to seeing the impact of your research!

🎉 Happening Now! The EASD Scientists Training Course 2025 is in full swing this week at the Institut d’Investigacions Bi...
12/11/2025

🎉 Happening Now! The EASD Scientists Training Course 2025 is in full swing this week at the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) in beautiful Barcelona, Spain! 🇪🇸

After two inspiring days of lectures, discussions, and sessions, participants are diving even deeper into an exciting week of exchange, collaboration, and skill-building in diabetes research.

📸 👇 Take a look at the image below and join us in wishing all participants continued success and inspiration throughout the week!

Supported by Lilly Diabetes International

12/11/2025

Are stem cell-derived islets the key to a cure for type 1 diabetes?

👉 Early trial data are promising, says Prof. Matthias Hebrok in this new Expert Insights episode. It is certain that, once transplanted, stem cell-derived islets are functional, yet important questions around their safety are still under investigation.

📺 Watch the entire episode on the EASD e-Learning platform: https://easd-elearning.eu/episode/346/Stem-cell-derived-beta-cell-for-transplantation.html

📢 The second EASD Diabetes Technology School is now open for applications:📅 24 - 26 April 2026 | 📍 Vienna, AustriaThis 3...
12/11/2025

📢 The second EASD Diabetes Technology School is now open for applications:

📅 24 - 26 April 2026 | 📍 Vienna, Austria

This 3-day course is designed for clinically qualified healthcare professionals aiming to advance their expertise in diabetes technology. Participants will gain hands-on insights into continuous glucose monitoring, automated insulin delivery, and digital health platforms with a focus on practical implementation in clinical practice.

🕛 Apply by 5 January 2026

🔗 Learn more and apply: https://www.easd.org/education/meetings-and-courses/diabetes-technology-school/diabetes-tech-school-2026/

Don’t miss this opportunity to enhance your skills and stay at the forefront of diabetes care.

🧠 Meet Prof. Fredrik Bäckhed (University of Gothenburg), recipient of the 2023  /Novo Nordisk A/S Programme for Diabetes...
11/11/2025

🧠 Meet Prof. Fredrik Bäckhed (University of Gothenburg), recipient of the 2023 /Novo Nordisk A/S Programme for Diabetes Research in Europe grant.

His project, “Gut microbial regulation of colonic GLP-1 production and effects on gut physiology”, aims to identify the role of colonic GLP-1 on gut physiology by utilizing mice that were deficient GLP-1 production, specifically in the colon.

During the project, his team uncovered that colonic GLP-1 is required for maintaining normal gut function and survival in the absence of gut bacteria. They went on to develop a dedicated mouse model to study how this locally produced GLP-1 shapes intestinal physiology and host-microbe interactions.

🗣️ “It provided the means for us to develop and finish our projects based on initial preliminary observations.” - Prof. Bäckhed reflects on the transformative impact of the award.

📖 Read the full publication: https://www.sciencedirect.com/science/article/pii/S2212877824000553?via%3Dihub
💡 Explore EFSD opportunities: https://lnkd.in/d_TKX2sH

Programme supported by Novo Nordisk

🚨 Last chance to apply! Applications are still open for the role of Editor-in-Chief of Diabetologia, European Associatio...
11/11/2025

🚨 Last chance to apply!

Applications are still open for the role of Editor-in-Chief of Diabetologia, European Association for the Study of Diabetes flagship journal dedicated to advancing diabetes research.

🕑 Application deadline: 17 November 2025.

Calling all accomplished physicians and/or scientists passionate about shaping the EASD’s journal’s future and driving excellence in diabetes research, don’t miss this opportunity.

🔗👉 Apply now: https://lnkd.in/eKvdztRK

📢 Job Opportunity: The European Association for the Study of Diabetes is inviting applications for the position of Editor-in-Chief of its flagship journal, Diabetologia.

This prestigious, peer-reviewed publication focuses on original clinical, translational, and experimental research across all aspects of diabetes and related subjects.

If you’re an accomplished physician and/or scientist eager to shape the future of Diabetologia and contribute to advancing diabetes research globally, this is an exceptional opportunity to lead one of the field’s most respected journals.

🗓️ Closing date: 17 November 2025

Learn more 👇 and apply 👉 https://tinyurl.com/diab-eic-job-ad

We’re thrilled to confirm the 2nd Early Career Academy Meeting:📅 30 March - 1 April 2026 | 📍 Düsseldorf, GermanyThis mee...
10/11/2025

We’re thrilled to confirm the 2nd Early Career Academy Meeting:

📅 30 March - 1 April 2026 | 📍 Düsseldorf, Germany

This meeting will bring together early career researchers to connect & collaborate on advancing diabetes research & care.

📝 Apply by 2 December 2025

🔗👉 https://www.easd.org/academy/academy-activities/eca-meeting-2026/

💻🗣️   Alert! Join the EASD Early Career Academy webinar this World Diabetes Day with Prof. Gernot Desoye (Medizinische U...
07/11/2025

💻🗣️ Alert! Join the EASD Early Career Academy webinar this World Diabetes Day with Prof. Gernot Desoye (Medizinische Universität Graz).

Discover how the placenta plays a central role in pregnancy outcomes: from early maternal glucose-insulin dynamics to the mechanisms that help protect the fetal brain later in development.

📅 14 November 2025 | 🕓 16:00 CET

🔗 Register here: https://us06web.zoom.us/webinar/register/WN_5yWiAvvQSSutjto__7GVSw/registration

🔁 The EASD Early Career Academy continues its series!

Next up on : Prof. Gernot Desoye (Medizinische Universität Graz) explores how the placenta influences pregnancy outcomes and fetal development.

Don’t miss this insightful session on 📅 14 November 2025 | 🕛 16:00 pm CET

Register now 👉 https://us06web.zoom.us/webinar/register/WN_5yWiAvvQSSutjto__7GVSw #/registration

🎙️ Weekend listening recommendation!At   in Vienna, Prof. Raphael Scharfmann (Inserm) was awarded the 19th Albert Renold...
07/11/2025

🎙️ Weekend listening recommendation!

At in Vienna, Prof. Raphael Scharfmann (Inserm) was awarded the 19th Albert Renold Prize for his groundbreaking work on pancreatic beta cells and the future of type 1 diabetes therapies.

In the next episode of Diabetes Insights - Breakthroughs and Innovators, Prof. Scharfmann shares the latest in stem cell advances and the quest to measure beta cell mass in living patients, his lecture highlighted how fundamental biology is shaping next-generation diabetes care.

🎧👉 Listen now: https://www.easd.org/media-centre/podcasts/

Adresse

EASD/Rheindorfer Weg 3
Düsseldorf
40591

Öffnungszeiten

Montag 08:00 - 17:00
Dienstag 08:00 - 17:00
Mittwoch 08:00 - 17:00
Donnerstag 08:00 - 17:00
Freitag 08:00 - 17:00

Telefon

+492117584690

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von European Association for the Study of Diabetes erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an European Association for the Study of Diabetes senden:

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

The Active Membership of the Association currently numbers more than 4,000 individuals from over 100 countries throughout the world. The Association also bestows Honorary Membership on any individual whose medical or scientific contribution to diabetes research has been outstanding; the first Honorary Member of the Association was Charles Best. The Association is governed by an Executive Committee chaired by the President. The Annual Meeting of the Association is held in a different European city each year. Abstracts are invited from members as well as non-members. All abstracts are anonymously reviewed by a Programme Committee, chaired by the Honorary Secretary. The EASD was one of the first international Associations to introduce the anonymous review of abstracts. The high quality of scientific research presented at the Annual Meetings is attested to by the increasing participation. The scientific programme of the Meeting, providing titles of the lectures and symposia, is made available online at a very early stage. Once confirmed, the speakers' names are made available and before the start of the Meeting all abstracts accepted for presentation can be accessed online. A search function assists the visitor in finding abstracts in their field of interest. Webcasts, poster presentations from the EASD Annual Meeting can be accessed via the EASD website.

EASD Postgraduate Education Courses have been organised by the Association since 1972 and, since then, over 25,000 medical professionals have taken part.

In 1999, the EASD increased its commitment to stimulate diabetes research in Europe by creating the European Foundation for the Study of Diabetes (EFSD).

Since its inception, EFSD has committed over Euro 100 million to diabetes research in Europe by various funding means.